Deepika Rachel Pakianathan's Insider Trades & SAST Disclosures
Deepika Rachel Pakianathan's most recent trade in Mereo Biopharma Group Plc - ADR was a trade of 55,000 Share Options (Right to buy) done . Disclosure was reported to the exchange on Feb. 5, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Deepika Rachel Pakianathan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 55,000 | 55,000 | - | - | Share Options (Right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 4.43 per share. | 22 Aug 2024 | 105,244 | 0 | - | 4.4 | 466,210 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 55,000 | 0 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 55,000 | 0 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.94 per share. | 22 Aug 2024 | 43,485 | 103,173 | - | 0.9 | 40,876 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.31 per share. | 22 Aug 2024 | 38,953 | 59,688 | - | 1.3 | 51,028 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 31,500 | 0 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 15,000 | 30,000 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.72 per share. | 22 Aug 2024 | 12,418 | 20,735 | - | 2.7 | 33,777 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 11,000 | 0 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.84 per share. | 22 Aug 2024 | 6,492 | 8,317 | - | 1.8 | 11,945 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2024 | 5,500 | 0 | - | - | Share Options (right to buy) | |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.87 per share. | 22 Aug 2024 | 2,071 | 105,244 | - | 3.9 | 8,015 | American Depositary Shares representing Ordinary Shares |
| Mereo Biopharma Group Plc ... | Deepika Rachel Pakianathan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 22 Aug 2024 | 1,825 | 1,825 | - | 3 | 5,475 | American Depositary Shares representing Ordinary Shares |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 05 Jun 2024 | 463,518 | 346,615 (0%) | 0% | 1.0 | 444,143 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 05 Jun 2024 | 229,308 | 0 (0%) | 0% | 1.0 | 218,003 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 05 Jun 2024 | 117,307 | 229,308 (0%) | 0% | 1.0 | 115,289 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 05 Jun 2024 | 4,526 | 3,385 (0%) | 0% | 1.0 | 4,337 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 05 Jun 2024 | 2,240 | 0 (0%) | 0% | 1.0 | 2,130 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.98 per share. | 05 Jun 2024 | 1,145 | 2,240 (0%) | 0% | 1.0 | 1,125 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 31 May 2024 | 357,256 | 1,147,875 (1%) | 0% | 1.0 | 357,506 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 337,742 | 810,133 (1%) | 0% | 1.0 | 321,564 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 202,418 | 1,505,131 (2%) | 0% | 1.0 | 193,107 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 31 May 2024 | 3,488 | 11,209 (0%) | 0% | 1.0 | 3,490 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 3,298 | 7,911 (0%) | 0% | 1.0 | 3,140 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 0.95 per share. | 31 May 2024 | 1,976 | 14,697 (0%) | 0% | 1.0 | 1,885 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 69,000 | 69,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 23,576 | 23,576 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 10,537 | 47,416 (0%) | 0% | 0 | Ordinary Shares | |
| Mereo Biopharma Group Plc ... | Rachel Pakianathan Deepika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2024 | 45,000 | 45,000 | - | - | Share Options (Right to buy) | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 34,000 | 34,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 22,044 | 22,044 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2023 | 9,132 | 36,879 (0%) | 0% | 0 | Ordinary Shares | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Jun 2022 | 322,825 | 1,918,298 (2%) | 0% | 6.5 | 2,099,428 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 08 Jun 2022 | 209,455 | 1,708,843 (2%) | 0% | 6.2 | 1,294,390 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.50 per share. | 08 Jun 2022 | 3,152 | 18,731 (0%) | 0% | 6.5 | 20,498 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 08 Jun 2022 | 2,045 | 16,686 (0%) | 0% | 6.2 | 12,638 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Jun 2022 | 1,294 | 1,707,549 (2%) | 0% | 6.0 | 7,766 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 08 Jun 2022 | 13 | 16,673 (0%) | 0% | 6 | 78 | Common Stock |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 28,000 | 28,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 9,852 | 27,747 (0%) | 0% | 0 | Ordinary Shares | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 23,900 | 23,900 | - | - | Nonstatutory Stock Option (right to buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 9,828 | 17,895 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2021 | 6,000 | 6,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 12,000 | 12,000 | - | - | Share Option (Right to Buy) | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 8,067 | 8,067 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 5,000 | 5,000 | - | - | Share Option (Right to Buy) | |
| Karyopharm Therapeutics Inc | Deepika Rachel Pakianathan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 16,400 | 16,400 | - | - | Nonstatutory Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges